A team of SDSC researchers recently created a pharmacophore model and conducted data mining of the database of drugs approved by the U.S. Federal Drug Administration (FDA) to find potential inhibitors of papain-like protease of SARS-CoV2, one of the main viral proteins responsible for COVID-19
Researchers from UC San Diego and UC Santa Barbara combine physics and biology to find that the physical environment where cells migrate through tight spaces is worth considering when studying conditions like development of the brain or movement of immune cells through lymph nodes and tumors.
Nanoengineers at UC San Diego have developed new and improved probes, known as positive controls, that could make it easier to validate rapid, point-of-care diagnostic tests for COVID-19 across the globe. The advance could help expand testing to low-resource, underserved areas.
University of California San Diego has been selected by the NIH to lead and administer an international seven-year, $28-million grant for HIV/AIDS clinical trials.
UC San Diego researchers discovered that the makeup of a person’s gut microbiome is linked to their levels of active vitamin D, and revealed a new understanding of vitamin D and how it’s typically measured.
A team fielded for the first time by SDSC and UC San Diego achieved 4th place overall out of 19 teams in the Student Cluster Competition, held during the annual Supercomputing Conference (SC20).
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
